Evidence map›Paper›PMID 31992984›Full record

ReviewFrontiers in pharmacology2019

Scaffold-Based Gene Therapeutics for Osteochondral Tissue Engineering.

Xin Yan, You-Rong Chen, Yi-Fan Song, Meng Yang, Jing Ye, Gang Zhou, Jia-Kuo Yu

Open access · goldAbstract readReview
In one paragraph

Review in Frontiers in pharmacology, 2019. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 20 papers.

0numbers the graph read from it
0cells of the map it votes in
20citing papers in PubMed
2.2field-weighted citation impact, top 12% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

20 citing papers in PubMed, 39 citations in OpenAlex.

  1. Review
  2. Article
  3. Review
  4. Review
  5. Review
  6. Review
  7. Article
  8. Article
  9. Review
  10. Review
  11. Review
  12. Review
  13. Review
  14. Review
  15. Article
  16. Article
  17. Review
  18. Genetics in Cartilage Lesions: Basic Science and Therapy Approaches.International journal of molecular sciences · 2020
    Review
  19. Review
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors at 3 institutions in 1 country.

Xin YanKnee Surgery Department of the Institute of Sports Medicine, Peking University Third Hospital, Beijing, China.
You-Rong ChenKnee Surgery Department of the Institute of Sports Medicine, Peking University Third Hospital, Beijing, China.
Yi-Fan SongKnee Surgery Department of the Institute of Sports Medicine, Peking University Third Hospital, Beijing, China.
Meng YangKnee Surgery Department of the Institute of Sports Medicine, Peking University Third Hospital, Beijing, China.
Jing YeKnee Surgery Department of the Institute of Sports Medicine, Peking University Third Hospital, Beijing, China.
Gang ZhouKey Laboratory for Biomechanics and Mechanobiology of Ministry of Education, School of Biological Science and Medical Engineering, Beihang University, Beijing, China.
Jia-Kuo YuKnee Surgery Department of the Institute of Sports Medicine, Peking University Third Hospital, Beijing, China.
Peking University · CNPeking University Third Hospital · CNBeihang University · CN

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Significant progress in osteochondral tissue engineering has been made for biomaterials designed to deliver growth factors that promote tissue regeneration. However, due to diffusion characteristics of hydrogels, the accurate delivery of signaling molecules remains a challenge. In comparison to the direct delivery of growth factors, gene therapy can overcome these challenges by allowing the simultaneous delivery of growth factors and transcription factors, thereby enhancing the multifactorial processes of tissue formation. Scaffold-based gene therapy provides a promising approach for tissue engineering through transfecting cells to enhance the sustained expression of the protein of interest or through silencing target genes associated with bone and joint disease. Reports of the efficacy of gene therapy to regenerate bone/cartilage tissue regeneration are widespread, but reviews on osteochondral tissue engineering using scaffold-based gene therapy are sparse. Herein, we review the recent advances in gene therapy with a focus on tissue engineering scaffolds for osteochondral regeneration.

Indexed as

gene therapymicroRNAsosteochondral regenerationscaffoldtissue engineering

Identifiers

PMID31992984
PMCPMC6970981
OpenAlexW2999404523

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.